Back
Review: Surgical Treatment of Type 2 Diabetes
María Dolores Hellín Gil, Pedro Pujante Alarcón, Alfonso López Ruiz, María Ángeles Ibañez, Alicia Hernández Torres, Ana Belén Hernández Cascales
Pharmacol. Pharm. Vol.5 No.1, January 09, 2014  DOI: 10.4236/pp.2014.51005
       (PDF  134K)     HTML      XML
Evolution of Biochemical Effects of Byetta® in Type 2 Diabetics with Cardiovascular Risk
Alfonso López Ruiz, María Ángeles Ibáñez Gil, Pedro Pujante Alarcón, Alicia Hernández Torres, Ana Belen Hernández Cascales, María Dolores Hellín Gil
Pharmacol. Pharm. Vol.4 No.9, December 11, 2013  DOI: 10.4236/pp.2013.49094
       (PDF  203K)     HTML     
Statins and Sepsis Literature Review
Alicia Hernández Torres, Ana Belén Hernández Cascales, Pedro Pujante Alarcón, Alfonso López Ruiz, María Ángeles Ibáñez Gil, María Dolores Hellín Gil
Pharmacol. Pharm. Vol.4 No.8, November 08, 2013  DOI: 10.4236/pp.2013.48082
       (PDF  171K)     HTML     
Morbid Obesity in Diabetes Mellitus Type 2 and Exenatide
María Angeles Ibañez Gil, Alfonso López Ruiz, Alicia Hernández Torres, Ana Belén Hernández Cascales, Pedro Pujante Alarcon, María Dolores Hellín Gil
Pharmacol. Pharm. Vol.5 No.2, February 10, 2014  DOI: 10.4236/pp.2014.52020
       (PDF  119K)     HTML     
Pleiotropic Effects of GLP-1. Cardiovascular Evidence of Effectiveness
Pedro Pujante Alarcón, Ana Belén Hernández Cascales, Alfonso López Ruiz, María Ángeles Ibañez Gil, Alicia Hernández Torres, María Dolores Hellín Gil
Pharmacol. Pharm. Vol.4 No.9, December 06, 2013  DOI: 10.4236/pp.2013.49091
       (PDF  166K)     HTML     
 
 
Top